Jill C. Fehrenbacher, PhD
Affiliations: | Pharmacology and Toxicology | Indiana University School of Medicine, Indianapolis, IN, United States |
Area:
pain, neurotrophins, estradiol, estrogenGoogle:
"Jill Fehrenbacher"Mean distance: 16.34 (cluster 31) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentor| Michael R. Vasko | grad student | 2001-2005 | Indiana University | |
| (The contribution of inflammation and inflammatory mediators to sensitization of sensory neurons.) | ||||
| Ken M. Hargreaves | post-doc | 2005-2009 | University of Texas Health Science Center at San Antonio | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Behrouzi A, Xia H, Thompson EL, et al. (2022) Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons. International Journal of Molecular Sciences. 23 |
| Cunningham GM, Shen F, Wu X, et al. (2022) The impact of SBF2 on taxane-induced peripheral neuropathy. Plos Genetics. 18: e1009968 |
| McCarson KE, Fehrenbacher JC. (2021) Models of Inflammation: Carrageenan- or Complete Freund's Adjuvant (CFA)-Induced Edema and Hypersensitivity in the Rat. Current Protocols. 1: e202 |
| Cunningham G, Cantor E, Wu X, et al. (2020) Abstract P5-07-09: Modeling taxane-induced peripheral neuropathy ex vivo using patient-derived neurons Cancer Research. 80 |
| Staff NP, Fehrenbacher JC, Caillaud M, et al. (2019) Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems. Experimental Neurology. 113121 |
| Sun S, Diggins NH, Gunderson ZJ, et al. (2019) No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing. Bone. 115109 |
| Kelley MR, Messmann RA, Fehrenbacher J. (2018) Novel first-in-class small molecule targeting APE1/Ref-1 to prevent and treat chemotherapy-induced peripheral neuropathy (CIPN). Journal of Clinical Oncology. 36: 229-229 |
| Shah FL, Atallah N, Grimard M, et al. (2018) Abstract 4802: Combination therapy in PDAC involving blockade of the APE1/Ref-1 signaling pathway: An investigation into drug synthetic lethality and anti-neuropathy therapeutic approach Cancer Research. 78: 4802-4802 |
| Fehrenbacher JC, Guo C, Kelley MR, et al. (2017) DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1. Neuroscience |
| Darby LM, Meng H, Fehrenbacher JC. (2017) Paclitaxel inhibits the activity and membrane localization of PKCα and PKCβI/II to elicit a decrease in stimulated calcitonin gene-related peptide release from cultured sensory neurons. Molecular and Cellular Neurosciences |